Search

everythinglearnresearchcommunity

for

Search:↓

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Skin aging is largely due to differences in stiffness and elasticity between skin layers, leading to wrinkles.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Vascular Surgery should become an independent discipline with its own board for a better future.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Polycystic Ovary Syndrome (PCOS) was found in 3.86% of tenth-grade girls in Guangzhou, China, with higher rates in overweight and obese girls, suggesting diagnosis should focus on hyperandrogenemia.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

A complex X chromosome rearrangement can increase the risk of multiple autoimmune diseases.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Retinoic acid affects male and female muscle energy use and function differently.

Minoxidil, a common alopecia medication, might cause eye changes due to its properties and lack of tissue selectivity.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.